The global smart inhalers market was valued at US$ 1,006.6 Mn in 2017 and is expected to reach US$ 3,674.6 Mn by 2026, expanding at a CAGR of 15.7% from 2018 to 2026.
Market Insights
According to the research findings of the World Health Organization (WHO), chronic obstructive pulmonary disease is responsible for 5% of global deaths annually. There is no permanent cure for chronic respiratory illness such as COPD, asthma, and bronchitis. Immediate symptomatic relief provided by respiratory inhalation is the best possible cure, hence smart inhalers possess impressive market growth in the near future due to excellent patient adherence and compliance to the treatment regimen.
Metered dose inhalers (MDIs) are reigning the type segment for smart inhalers market. Excellent PK/PD profile achieved during the drug delivery and increasing demand in geriatric patients suffering from chronic illness drive the metered dose inhalers market growth. Dry powder inhalers have gained tremendous attraction in recent times due to the drug irritation and severe adverse effects caused by the propellants employed in MDIs. Nebulizers are widely employed in pediatric patients due to higher safety and efficacy associated with the drug delivery system.
Chronic obstructive pulmonary disease is currently leading the application segment for smart inhalers market. The rampant growth of smokers in developed countries and rising industrialization in developing nation has led to the rise of air pollution and exposure to occupational dust and fumes. Asthma will be the fastest growing market in the near future due to the rising prevalence of hereditary asthma in children and requires immediate symptomatic relief due to constriction of respiratory muscles.
In the present scenario, North America with a share of 38% is leading the regional segment for smart inhalers market. The key features that contribute towards its supremacy are rampant growth in tobacco smokers and domicile of major players such as Propeller Health, Cohero Health, 3M Healthcare etc. Europe accounts for 29% market share, on account of the increasing number of pediatric patients suffering from asthma and strategic collaboration between pharmaceutical giants and software companies to provide a smart inhaler system. The Asia Pacific with a market share of 20% will be the fastest growing regional segment during the forecast period on account of increasing geriatric patients suffering from chronic pulmonary illness and emergence of local players exerting stringent competition to western giants in smart inhalers market.
Companies in collaboration with pharmaceutical key players engaged in the development of smart inhalers are Amiko, Adherium Limited, Cohero Health, 3M Healthcare, Opko Health, Inc., Propeller Health, Philips Respironics, Sensirion AG, Teva Pharmaceutical Industries Limited and Vectura Group, Plc.
Key Market Movements:
This product will be delivered within 2 business days.
Market Insights
According to the research findings of the World Health Organization (WHO), chronic obstructive pulmonary disease is responsible for 5% of global deaths annually. There is no permanent cure for chronic respiratory illness such as COPD, asthma, and bronchitis. Immediate symptomatic relief provided by respiratory inhalation is the best possible cure, hence smart inhalers possess impressive market growth in the near future due to excellent patient adherence and compliance to the treatment regimen.
Metered dose inhalers (MDIs) are reigning the type segment for smart inhalers market. Excellent PK/PD profile achieved during the drug delivery and increasing demand in geriatric patients suffering from chronic illness drive the metered dose inhalers market growth. Dry powder inhalers have gained tremendous attraction in recent times due to the drug irritation and severe adverse effects caused by the propellants employed in MDIs. Nebulizers are widely employed in pediatric patients due to higher safety and efficacy associated with the drug delivery system.
Chronic obstructive pulmonary disease is currently leading the application segment for smart inhalers market. The rampant growth of smokers in developed countries and rising industrialization in developing nation has led to the rise of air pollution and exposure to occupational dust and fumes. Asthma will be the fastest growing market in the near future due to the rising prevalence of hereditary asthma in children and requires immediate symptomatic relief due to constriction of respiratory muscles.
In the present scenario, North America with a share of 38% is leading the regional segment for smart inhalers market. The key features that contribute towards its supremacy are rampant growth in tobacco smokers and domicile of major players such as Propeller Health, Cohero Health, 3M Healthcare etc. Europe accounts for 29% market share, on account of the increasing number of pediatric patients suffering from asthma and strategic collaboration between pharmaceutical giants and software companies to provide a smart inhaler system. The Asia Pacific with a market share of 20% will be the fastest growing regional segment during the forecast period on account of increasing geriatric patients suffering from chronic pulmonary illness and emergence of local players exerting stringent competition to western giants in smart inhalers market.
Companies in collaboration with pharmaceutical key players engaged in the development of smart inhalers are Amiko, Adherium Limited, Cohero Health, 3M Healthcare, Opko Health, Inc., Propeller Health, Philips Respironics, Sensirion AG, Teva Pharmaceutical Industries Limited and Vectura Group, Plc.
Key Market Movements:
- An increasing number of geriatric patients suffering from chronic respiratory illness
- A significant increase in the number of tobacco smokers and rising air pollution
- A recent launch of innovative smart apps and wireless services to enhance drug delivery and patient compliance
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Preface1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global Smart Inhalers Market Portraiture
2.2. Global Smart Inhalers Market, by Type, 2017 (US$ Mn)
2.3. Global Smart Inhalers Market, by Application, 2017 (US$ Mn)
2.4. Global Smart Inhalers Market, by Geography, 2017 (US$ Mn)
Chapter 3. Smart Inhalers Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Smart Inhalers Market, by Key Players, 2017
Chapter 4. Global Smart Inhalers Market, by Type
4.1. Overview
4.2. Metered Dose Inhalers
4.3. Dry Powder Inhalers
4.4. Nebulizers
Chapter 5. Global Smart Inhalers Market, by Application
5.1. Overview
5.2. Chronic Obstructive Pulmonary Disease (COPD)
5.3. Asthma
5.4. Others
Chapter 6. Global Smart Inhalers Market, by Geography
6.1. Overview
6.2. North America Smart Inhalers Market Analysis, 2016 – 2026
6.2.1. North America Smart Inhalers Market, by Type, 2016 – 2026 (US$ Mn)
6.2.2. North America Smart Inhalers Market, by Application, 2016 – 2026 (US$ Mn)
6.2.3. North America Smart Inhalers Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Smart Inhalers Market Analysis, 2016 – 2026
6.3.1. Europe Smart Inhalers Market, by Type, 2016 – 2026 (US$ Mn)
6.3.2. Europe Smart Inhalers Market, by Application, 2016 – 2026 (US$ Mn)
6.3.3. Europe Smart Inhalers Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Smart Inhalers Market Analysis, 2016 – 2026
6.4.1. Asia Pacific Smart Inhalers Market, by Type, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific Smart Inhalers Market, by Application, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific Smart Inhalers Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America Smart Inhalers Market Analysis, 2016 – 2026
6.5.1. Latin America Smart Inhalers Market, by Type, 2016 – 2026 (US$ Mn)
6.5.2. Latin America Smart Inhalers Market, by Application, 2016 – 2026 (US$ Mn)
6.5.3. Latin America Smart Inhalers Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa Smart Inhalers Market Analysis, 2016 – 2026
6.6.1. MEA Smart Inhalers Market, by Type, 2016 – 2026 (US$ Mn)
6.6.2. MEA Smart Inhalers Market, by Application, 2016 – 2026 (US$ Mn)
6.6.3. MEA Smart Inhalers Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA
Chapter 7. Company Profiles
7.1. Amiko
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Adherium Limited
7.3. Cohero Health
7.4. 3M Healthcare
7.5. Opko Health, Inc.
7.6. Propeller Health
7.7. Philips Respironics
7.8. Sensirion AG
7.9. Teva Pharmaceutical Industries Ltd.
7.10. Vectura Group, Plc.List of Figures
FIG. 1 Smart Inhalers Market: Research Methodology
FIG. 2 Smart Inhalers: Market Segmentation
FIG. 3 Global Smart Inhalers Market, by Type, 2017 (US$ Mn)
FIG. 4 Global Smart Inhalers Market, by Application, 2017 (US$ Mn)
FIG. 5 Global Smart Inhalers Market, by Geography, 2017 (US$ Mn)
FIG. 6 Attractive Investment Proposition: by Geography, 2017
FIG. 7 Competitive Analysis: Global Smart Inhalers Market, by Key Players, 2017
FIG. 8 Global Metered Dose Smart Inhalers Market, 2016 – 2026 (US$ Mn)
FIG. 9 Global Dry Powder Smart Inhalers Market, 2016 – 2026 (US$ Mn)
FIG. 10 Global Nebulizers Smart Inhalers Market, 2016 – 2026 (US$ Mn)
FIG. 11 Global COPD Market for Smart Inhalers, 2016 – 2026 (US$ Mn)
FIG. 12 Global Asthma Market for Smart Inhalers, 2016 – 2026 (US$ Mn)
FIG. 13 Global Other Applications Market for Smart Inhalers, 2016 – 2026 (US$ Mn)
FIG. 14 U.S. Smart Inhalers Market, 2016 – 2026 (US$ Mn)
FIG. 15 Canada Smart Inhalers Market, 2016 – 2026 (US$ Mn)
FIG. 16 U.K. Smart Inhalers Market, 2016 – 2026 (US$ Mn)
FIG. 17 Germany Smart Inhalers Market, 2016 – 2026 (US$ Mn)
FIG. 18 Rest of Europe Smart Inhalers Market, 2016 – 2026 (US$ Mn)
FIG. 19 China Smart Inhalers Market, 2016 – 2026 (US$ Mn)
FIG. 20 Japan Smart Inhalers Market, 2016 – 2026 (US$ Mn)
FIG. 21 Rest of Asia Pacific Smart Inhalers Market, 2016 – 2026 (US$ Mn)
FIG. 22 Brazil Smart Inhalers Market, 2016 – 2026 (US$ Mn)
FIG. 23 Mexico Smart Inhalers Market, 2016 – 2026 (US$ Mn)
FIG. 24 Rest of Latin America Smart Inhalers Market, 2016 – 2026 (US$ Mn)
FIG. 25 GCC Smart Inhalers Market, 2016 – 2026 (US$ Mn)
FIG. 26 Rest of MEA Smart Inhalers Market, 2016 – 2026 (US$ Mn)
List of Tables
TABLE 1 Global Smart Inhalers Market Portraiture
TABLE 2 Global Smart Inhalers Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global Smart Inhalers Market , by Application, 2016 – 2026 (US$ Mn)
TABLE 4 Global Smart Inhalers Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 North America Smart Inhalers Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 6 North America Smart Inhalers Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 7 North America Smart Inhalers Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe Smart Inhalers Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 9 Europe Smart Inhalers Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 10 Europe Smart Inhalers Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific Smart Inhalers Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 12 Asia Pacific Smart Inhalers Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 13 Asia Pacific Smart Inhalers Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Latin America Smart Inhalers Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 15 Latin America Smart Inhalers Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 16 Latin America Smart Inhalers Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 Middle East and Africa Smart Inhalers Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 18 Middle East and Africa Smart Inhalers Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 19 Middle East and Africa Smart Inhalers Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 20 Amiko: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Adherium Limited: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Cohero Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 3M Healthcare: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Opko Health, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Propeller Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 Philips Respironics: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 Sensirion AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Vectura Group, Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Companies Mentioned
- Amiko
- Adherium Limited
- Cohero Health
- 3M Healthcare
- Opko Health, Inc.
- Propeller Health
- Philips Respironics
- Sensirion AG
- Teva Pharmaceutical Industries Ltd.
- Vectura Group, Plc.
